|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.01%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
1.01%
|
US
|
NASDAQ
|
|
TWST
|
Twist Bioscience Corporation
|
1.00%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
1.00%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
0.99%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.99%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
0.98%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
0.98%
|
US
|
NASDAQ
|
|
ABBV
|
AbbVie Inc.
|
0.98%
|
US
|
NYSE
|
|
TGTX
|
TG Therapeutics, Inc.
|
0.97%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.97%
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.97%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
0.95%
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
0.95%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.95%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
0.95%
|
US
|
NASDAQ
|